Dear participant,

It is a pleasure to welcome you to the EUROTHROMBOSIS SCIENCE 2008: FOCUS ATHEROTHROMBOSIS we are organizing in Barcelona. This meeting is an activity of the Working Group on Thrombosis of the European Society of Cardiology and this time it is sponsored by the Spanish Society of Cardiology Section of Coronary Heart Disease and its Working Group on Cardiovascular Thrombosis.

I am pleased to announce this meeting that will help to develop intense scientific relations among groups interested in unveiling the causes, mechanisms, clinical implications, and therapeutical options in atherothrombosis.

I wish you have an excellent stay in Barcelona and a very profitable congress.

Lina Badimon

Thursday 11th December 2008

• 14:30 - Registration
• 15:00 - Welcome
  Prof. L. Badimon (Spain) / Prof. K. Huber (Austria)
• SYMPOSIA : What are clinical results teaching us on platelet function and thrombosis
  Chair: Prof. K. Huber (Austria), Prof. C. Macaya (Spain)
• 15:30 - Anti platelet treatment: Synergies or conflicts? Critical evaluation of trial data
  Prof K.A.A.Fox, Edinburgh (UK)
• 15:50 - What is it GRACE teaching us?
  Prof. D. Gulba, Düren, (Germany)
• 16:10 - Bleeding: Impact and Consecuence
  Prof. P.G. Steg, Paris (France)
• 16:30 - Why is it better to open mechanically than lyse pharmacologically?
  Prof. S.D. Kristensen, Aarhus (Denmark)
• 16:50 - Debate & Cofee
• 17:00 - 18:30 - Oral Communications
• 18:30 - 20:40 - Symposium LILLY
• 20:45 - Dinner Party

Friday 12th December 2008

• 09:30 - Lecture
  Chair: Prof. S.D. Kristensen
  tent thrombosis and in-stent restenosis: Mechanisms – Therapeutics – Clinical Results
  Prof. K. Huber (Austria)
• SYMPOSIA : Questions without response
  Chair: Prof. P.G. Steg (France), Prof. J.J. Badimon (USA)
• 10:00 - Hemoglobin and NO
  Prof. F. Andreotti, Roma (Italy)
• 10:20 - Revisiting Aspirin and thienopyridine "resistance"
  Prof. R. de Caterina, Chieti (Italy)
• 10:40 - Estrogen therapy: Why and when?
  Prof. F.W.A. Verheugt, Nijmegen, (Netherland)
• 11:00 - Debate & Cofee
• SYMPOSIA : Cell therapy: The hope
  Chair: Prof. K. A. Fox (U.K), Prof. JF. Martin (UK)
• 11:30 - Intracoronary injection of autologous mononuclear bone marrow cells: Pros and Cons
  Prof. H. Arnesen, Oslo (Norway)Prof. H. Arnesen, Oslo (Norway)
• 11:50 - Cell therapy: options and trends
  Prof. Fernández-Avilés, Madrid (Spain)
• 12:10 - Debate
• 12:30 - Lecture
  Chair Prof. H. Arnesen (Norway), Prof. C. Patrono (Italy)
  Magnetic resonance imaging: Is it ready for the vessel wall?
  Prof. JJ. Badimon, New York (USA)
• 13:00 - Lunch
• SYMPOSIA : Mechanisms in atherothrombosis
  Chair: Prof. R. de Caterina, (Italy), Prof. P. J.Grant, (UK)
• 14:30 - Platelet function
  Prof. J.A. Jakubowski, Indianapolis, (USA)
• 14:50 - Omega-3 fatty acids in atherothrombosis
  Prof. I. Seljeflot, Oslo (Norway)
• 15:10 - CD-36 in atherothrombosis
  Prof. J. McGregor, London (U.K)
• 15:30 - From obesity to atherothrombosis; are adipokines the culprits?
  Prof. J. Wojta, Vienna (Austria)
• 15:50 - The case of Cox-2 and Coxibs in cardiovascular disease
  Prof. C. Patrono, Rome (Italy).
• 16:10 - HDL in Atherothrombosis
  Dr. B. Ibañez, Madrid (Spain)
• 16:20 - Debate & Cofee
• 17:00 - 18:30 - Oral Communications
• 18:30 - End of session
• 21:00 - Dinner

Saturday 13th December 2008

• 09:30 - Oral Communications
  
• SYMPOSIA : New targets - I
  Chair Prof. F.W.A. Verheugt (Netherland), Prof. F. Andreotti (Italy)
• 10:30 - Ischemic protection - fact or fiction
  Dr. D. Garcia-Dorado, Barcelona (Spain)
• 10:50 - Proteomics in atherothrombosis
  Dr. T. Padró, Barcelona (Spain)
• 11:10 - Debate & Cofee
• SYMPOSIA : New targets - II
  Chair Prof. D. Gulba, (Germany), Prof. L. Badimon, (Spain)
• 11:30 - Angiogenesis in atherothrombotic plaques
  Prof. M.Slevin, Manchester/Barcelona (U.K/Spain)
• 11:50 - Biorevascularization
  Prof. JF. Martin, London (UK)
• 12:10 - Debate, Cofee & Snacks
• 12:30 - Closing REMARKS
  Prof. L. Badimon (Spain) / Prof. F. Andreotti (Italy)
  Research and Development in Europe. The case of Ireland
  Prof. D. Fitzgerald, Dublin (Ireland)
• 13:20 - End of Congress

Intense scientific research has led to our current understanding that atherogenesis, lipids and other risk factors inflammation, coagulation, platelets, fibrinolysis and atherosclerosis progression are closely linked.

This is the reason why the Working Group on Thrombosis of the European Society of Cardiology chose to organize the Eurothrombosis 2008 to foster an intense interdisciplinary discussion among clinicians and basic scientists working in the field about their latest perceptions of atherothrombotic mechanisms.

Our aim is to facilitate the transition of the new understanding of atherothrombosis from bench to bedside and the translation of current state of the art knowledge into general clinical practice.

This congress is an activity of the Working Group on Thrombosis of the European Society of Cardiology.

Scientific committee

• Prof. K. Huber FESC (Vienna - Austria)
• Dr. F. Andeotti FESC (Roma - Italy)
• Dr. S.D. Kristensen (Aarhus - Denmark)
• Prof. K.A. Fox FESC (Edimburgo, United Kingdom)
• Prof. L. Badimon (Barcelona, España)
• Prof. H. Arnesen (Oslo - Norway)
• Prof. R. De Caterina (Chiete - Italy)
• Prof. D. Gulba (Düren - Germany)
• Prof. P.G. Steg (Parins - France)
• Prof. F.W.A. Verheugt (Nijmegen - Netherland)

Abstract submission and selection

• Send your abstract as attachment to an e-mail message to: [email protected] object: EUROTHROMBOSIS 2008 (ABSTRACT)
• Clearly mention the name, institute, e-mail address, telephone number and fax number of the presenter in the e-mail message.
• Abstract must be received by May 30, 2008.
• All abstracts will be reviewed by the Organizing Committee.The final selection will be made November 10th.
• Between November 10-14 an e-mail message will be sent to all abstract submitters informing the status of their abstract (rejected or submitted).
• Registration fee will be waived for the presenting author of each accepted abstract.

Abstract instructions

• Use a MS-Word format or PDF.
• The abstract must be in English.
• 1 A4 page, 2 cm (3/4'') margins, Title (Arial 12), Text (Arial 10) underline name of the presenting author, give e-mail address
• The abstract (body text, table/figure) may not exceed 400 words.
• One simple table or figure (neat and in black-and-white) may be included at most (each representing 50 words). So in case a table or figure is included, the body text may not exceed 250 words.
• Mention 3 key words (consult the biannual list of keywords in Circulation).
• The use of standard abbreviations is desirable. Place special or unusual abbreviations in parenthesys after the full word the first time it appears in the body text.
• Use numericals to indicate numbers, except for the beginning of sentences.
• Organize your abstract as follows:
• Title (capitalize entire title, do not underline)
• Author (omit degrees and titles)
• Affiliations (list immediately after the last author, omit full address)
• Body text (purpose, methods, results and conclusion)

Notes

• The Organizing Committee of EUROTHROMBOSIS 2008 reserves the right to refuse any abstract if the scientific content is deemed insufficient. According to topic, selected abstracts will be presented either as oral communication or as poster. Notice regarding type of presentation will be forwarded to authors on July 15th 2007.
• Forward abstract form by e-mail at [email protected] and copy of appropriate bank remittance by fax to:+34 93 5565559.
• Abstract submission will not be processed without registration.
• Presenting authors will be informed by e-mail about abstract acceptance.
• Conference room will be equipped with computer and projector.

The deadline to submit abstracts is on 30th May 2008